Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2002 Sep;73(3):250–255. doi: 10.1136/jnnp.73.3.250

Home based management in multiple sclerosis: results of a randomised controlled trial

C Pozzilli 1, M Brunetti 1, A Amicosante 1, C Gasperini 1, G Ristori 1, L Palmisano 1, M Battaglia 1
PMCID: PMC1738043  PMID: 12185154

Abstract

Background: Home based medical care is a popular alternative to standard hospital care but there is uncertainty about its cost-effectiveness.

Objectives: To compare the effectiveness and the costs of multidisciplinary home based care in multiple sclerosis with hospital care in a prospective randomised controlled trial with a one year follow up.

Methods: 201 patients with clinically definite multiple sclerosis were studied. They were randomised in a ratio 2:1 to an intervention group (133) or a control group (68). They were assessed at baseline and one year after randomisation with validated measures of physical and psychological impairment and quality of life (SF-36 health survey). The costs to the National Health Service over the one year follow up were calculated by a cost minimisation analysis.

Results: There were no differences in functional status between the home based care group and the hospital group. There was a significant difference between the two groups favouring home based management in four SF-36 health dimensions—general health, bodily pain, role-emotional, and social functioning (all p ≤ 0.001). The cost of home based care was slightly less (822 euros/patient/year) than hospital care, mainly as a result of a reduction in hospital admissions.

Conclusions: Comprehensive planning of home based intervention implemented by an interdisciplinary team and designed specifically for people with multiple sclerosis may provide a cost-effective approach to management and improve the quality of life.

Full Text

The Full Text of this article is available as a PDF (221.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson C., Rubenach S., Mhurchu C. N., Clark M., Spencer C., Winsor A. Home or hospital for stroke rehabilitation? results of a randomized controlled trial : I: health outcomes at 6 months. Stroke. 2000 May;31(5):1024–1031. doi: 10.1161/01.str.31.5.1024. [DOI] [PubMed] [Google Scholar]
  2. Bredin M., Corner J., Krishnasamy M., Plant H., Bailey C., A'Hern R. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ. 1999 Apr 3;318(7188):901–904. doi: 10.1136/bmj.318.7188.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carton H., Loos R., Pacolet J., Versieck K., Vlietinck R. Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium) J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):444–450. doi: 10.1136/jnnp.64.4.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cummings J. E., Hughes S. L., Weaver F. M., Manheim L. M., Conrad K. J., Nash K., Braun B., Adelman J. Cost-effectiveness of Veterans Administration hospital-based home care. A randomized clinical trial. Arch Intern Med. 1990 Jun;150(6):1274–1280. [PubMed] [Google Scholar]
  5. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  6. Freeman J. A., Hobart J. C., Langdon D. W., Thompson A. J. Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):150–156. doi: 10.1136/jnnp.68.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Freeman J. A., Hobart J. C., Thompson A. J. Does adding MS-specific items to a generic measure (the SF-36) improve measurement? Neurology. 2001 Jul 10;57(1):68–74. doi: 10.1212/wnl.57.1.68. [DOI] [PubMed] [Google Scholar]
  8. Freeman J. A., Langdon D. W., Hobart J. C., Thompson A. J. The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol. 1997 Aug;42(2):236–244. doi: 10.1002/ana.410420216. [DOI] [PubMed] [Google Scholar]
  9. Freeman J. A., Thompson A. J. Community services in multiple sclerosis: still a matter of chance. J Neurol Neurosurg Psychiatry. 2000 Dec;69(6):728–732. doi: 10.1136/jnnp.69.6.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gundersen L. There's no place like home: the home health care alternative. Ann Intern Med. 1999 Oct 19;131(8):639–640. doi: 10.7326/0003-4819-131-8-199910190-00103. [DOI] [PubMed] [Google Scholar]
  11. Henriksson F., Fredrikson S., Masterman T., Jönsson B. Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neurol. 2001 Jan;8(1):27–35. doi: 10.1046/j.1468-1331.2001.00169.x. [DOI] [PubMed] [Google Scholar]
  12. Henriksson F, Jönsson B. The economic cost of multiple sclerosis in Sweden in 1994. Pharmacoeconomics. 1998 May;13(5 Pt 2):597–606. doi: 10.2165/00019053-199813050-00012. [DOI] [PubMed] [Google Scholar]
  13. Jolly K., Bradley F., Sharp S., Smith H., Thompson S., Kinmonth A. L., Mant D. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ. 1999 Mar 13;318(7185):706–711. doi: 10.1136/bmj.318.7185.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kidd D., Stewart G., Baldry J., Johnson J., Rossiter D., Petruckevitch A., Thompson A. J. The Functional Independence Measure: a comparative validity and reliability study. Disabil Rehabil. 1995 Jan;17(1):10–14. doi: 10.3109/09638289509166622. [DOI] [PubMed] [Google Scholar]
  15. Krupp L. B., LaRocca N. G., Muir-Nash J., Steinberg A. D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 Oct;46(10):1121–1123. doi: 10.1001/archneur.1989.00520460115022. [DOI] [PubMed] [Google Scholar]
  16. Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444–1452. doi: 10.1212/wnl.33.11.1444. [DOI] [PubMed] [Google Scholar]
  17. Naylor M. D., Brooten D., Campbell R., Jacobsen B. S., Mezey M. D., Pauly M. V., Schwartz J. S. Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. JAMA. 1999 Feb 17;281(7):613–620. doi: 10.1001/jama.281.7.613. [DOI] [PubMed] [Google Scholar]
  18. Nortvedt M. W., Riise T., Myhr K. M., Nyland H. I. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 1999 Sep 22;53(5):1098–1103. doi: 10.1212/wnl.53.5.1098. [DOI] [PubMed] [Google Scholar]
  19. Noseworthy J. H., Lucchinetti C., Rodriguez M., Weinshenker B. G. Multiple sclerosis. N Engl J Med. 2000 Sep 28;343(13):938–952. doi: 10.1056/NEJM200009283431307. [DOI] [PubMed] [Google Scholar]
  20. O'Connor P., Lee L., Ng P. T., Narayana P., Wolinsky J. S. Determinants of overall quality of life in secondary progressive MS: a longitudinal study. Neurology. 2001 Sep 11;57(5):889–891. doi: 10.1212/wnl.57.5.889. [DOI] [PubMed] [Google Scholar]
  21. Parkin D., Jacoby A., McNamee P., Miller P., Thomas S., Bates D. Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life. J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):144–149. doi: 10.1136/jnnp.68.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Petajan J. H., Gappmaier E., White A. T., Spencer M. K., Mino L., Hicks R. W. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol. 1996 Apr;39(4):432–441. doi: 10.1002/ana.410390405. [DOI] [PubMed] [Google Scholar]
  23. Pfennings L., Cohen L., Miller D., Gerbaud L., Vleugels L., Freeman J., Vernay D., Biolay S., Ketelaer P., Thompson A. Using the Short Form-36 with multiple sclerosis patients in five countries: a cross-cultural comparison. Psychol Rep. 1999 Aug;85(1):19–31. doi: 10.2466/pr0.1999.85.1.19. [DOI] [PubMed] [Google Scholar]
  24. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  25. Rothwell P. M., McDowell Z., Wong C. K., Dorman P. J. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ. 1997 May 31;314(7094):1580–1583. doi: 10.1136/bmj.314.7094.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Shepperd S., Iliffe S. The effectiveness of hospital at home compared with in-patient hospital care: a systematic review. J Public Health Med. 1998 Sep;20(3):344–350. doi: 10.1093/oxfordjournals.pubmed.a024778. [DOI] [PubMed] [Google Scholar]
  27. Solari A., Filippini G., Gasco P., Colla L., Salmaggi A., La Mantia L., Farinotti M., Eoli M., Mendozzi L. Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology. 1999 Jan 1;52(1):57–62. doi: 10.1212/wnl.52.1.57. [DOI] [PubMed] [Google Scholar]
  28. Stolp-Smith K. A., Atkinson E. J., Campion M. E., O'Brien P. C., Rodriguez M. Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN. Neurology. 1998 Jun;50(6):1594–1600. doi: 10.1212/wnl.50.6.1594. [DOI] [PubMed] [Google Scholar]
  29. Stuck A. E., Aronow H. U., Steiner A., Alessi C. A., Büla C. J., Gold M. N., Yuhas K. E., Nisenbaum R., Rubenstein L. Z., Beck J. C. A trial of annual in-home comprehensive geriatric assessments for elderly people living in the community. N Engl J Med. 1995 Nov 2;333(18):1184–1189. doi: 10.1056/NEJM199511023331805. [DOI] [PubMed] [Google Scholar]
  30. Vickrey B. G., Hays R. D., Genovese B. J., Myers L. W., Ellison G. W. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J Clin Epidemiol. 1997 May;50(5):557–569. doi: 10.1016/s0895-4356(97)00001-2. [DOI] [PubMed] [Google Scholar]
  31. Vickrey B. G., Hays R. D., Harooni R., Myers L. W., Ellison G. W. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995 Jun;4(3):187–206. doi: 10.1007/BF02260859. [DOI] [PubMed] [Google Scholar]
  32. Ware J. E., Jr, Sherbourne C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–483. [PubMed] [Google Scholar]
  33. Weinshenker B. G., Bass B., Rice G. P., Noseworthy J., Carriere W., Baskerville J., Ebers G. C. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989 Feb;112(Pt 1):133–146. doi: 10.1093/brain/112.1.133. [DOI] [PubMed] [Google Scholar]
  34. Whetten-Goldstein K., Sloan F. A., Goldstein L. B., Kulas E. D. A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler. 1998 Oct;4(5):419–425. doi: 10.1177/135245859800400504. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES